SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jameel Youssef, Shannon A. Novosad, Kevin L. Winthrop, Infection Risk and Safety of Corticosteroid Use, Rheumatic Disease Clinics of North America, 2016, 42, 1, 157

    CrossRef

  2. 2
    Altynay Shigayeva, Wallis Rudnick, Karen Green, Danny K. Chen, Walter Demczuk, Wayne L. Gold, Jennie Johnstone, Ian Kitai, Sigmund Krajden, Reena Lovinsky, Matthew Muller, Jeff Powis, Neil Rau, Sharon Walmsley, Gregory Tyrrell, Ari Bitnun, Allison McGeer, Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs, Clinical Infectious Diseases, 2016, 62, 2, 139

    CrossRef

  3. 3
    S. Marmor, Y. Kerroumi, Patient-specific risk factors for infection in arthroplasty procedure, Orthopaedics & Traumatology: Surgery & Research, 2016,

    CrossRef

  4. 4
    Takahiko Sugihara, Masayoshi Harigai, Targeting Low Disease Activity in Elderly-Onset Rheumatoid Arthritis: Current and Future Roles of Biological Disease-Modifying Antirheumatic Drugs, Drugs & Aging, 2016,

    CrossRef

  5. 5
    Mikiko Iguchi-Hashimoto, Motomu Hashimoto, Takao Fujii, Masahide Hamaguchi, Moritoshi Furu, Masahiro Ishikawa, Hiromu Ito, Noriyuki Yamakawa, Chikashi Terao, Keiichi Yamamoto, Wataru Yamamoto, Koichiro Ohmura, Tsuneyo Mimori, The association between serious infection and disease outcome in patients with rheumatoid arthritis, Clinical Rheumatology, 2016, 35, 1, 213

    CrossRef

  6. 6
    Noboru Takayanagi,, Biological agents and respiratory infections: Causative mechanisms and practice management, Respiratory Investigation, 2015, 53, 5, 185

    CrossRef

  7. 7
    Yves-Marie Pers, Roxane Schaub, Elodie Constant, Joseph Lambert, Marie Godfrin-Valnet, Clémentine Fortunet, Waafa Bourichi, Béatrice Pallot Prades, Daniel Wendling, Philippe Gaudin, Christian Jorgensen, Jean-Francis Maillefert, Hubert Marotte, Efficacy and safety of tocilizumab in elderly patients with rheumatoid arthritis, Joint Bone Spine, 2015, 82, 1, 25

    CrossRef

  8. 8
    Chun Chao, Roberto Rodriguez, John H. Page, Su-Jau Yang, Julie Huynh, Victoria M. Chia, History of chronic comorbidity and risk of chemotherapy-induced febrile neutropenia in patients with non-Hodgkin lymphoma not receiving granulocyte colony-stimulating factor prophylaxis, Leukemia & Lymphoma, 2015, 56, 1, 72

    CrossRef

  9. 9
    S. K. Brode, F. B. Jamieson, R. Ng, M. A. Campitelli, J. C. Kwong, J. M. Paterson, P. Li, A. Marchand-Austin, C. Bombardier, T. K. Marras, Increased risk of mycobacterial infections associated with anti-rheumatic medications, Thorax, 2015, 70, 7, 677

    CrossRef

  10. 10
    Rebecca Davies, Taunton R. Southwood, Lianne Kearsley-Fleet, Mark Lunt, Kimme L. Hyrich, Medically Significant Infections Are Increased in Patients With Juvenile Idiopathic Arthritis Treated With Etanercept: Results From the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study, Arthritis & Rheumatology, 2015, 67, 9
  11. 11
    Alyssa Parian, Christina Y. Ha, Older Age and Steroid Use Are Associated with Increasing Polypharmacy and Potential Medication Interactions Among Patients with Inflammatory Bowel Disease, Inflammatory Bowel Diseases, 2015, 1

    CrossRef

  12. 12
    Clément Lahaye, Zuzana Tatar, Jean-Jacques Dubost, Martin Soubrier, Overview of biologic treatments in the elderly, Joint Bone Spine, 2015, 82, 3, 154

    CrossRef

  13. 13
    Pauline Fitzgerald, Heidi J. Siddle, Michael R. Backhouse, E. Andrea Nelson, Prevalence and microbiological characteristics of clinically infected foot-ulcers in patients with rheumatoid arthritis: a retrospective exploratory study, Journal of Foot and Ankle Research, 2015, 8, 1

    CrossRef

  14. 14
    T. Sugihara, T. Ishizaki, T. Hosoya, S. Iga, W. Yokoyama, F. Hirano, N. Miyasaka, M. Harigai, Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis: a prospective cohort study (CRANE), Rheumatology, 2015, 54, 5, 798

    CrossRef

  15. 15
    Hong Yang, Arthur Kavanaugh, Adverse effects of golimumab in the treatment of rheumatologic diseases, Expert Opinion on Drug Safety, 2014, 13, 1, 103

    CrossRef

  16. 16
    Maurizio Cutolo, George D. Kitas, Piet L.C.M. van Riel, Burden of disease in treated rheumatoid arthritis patients: Going beyond the joint, Seminars in Arthritis and Rheumatism, 2014, 43, 4, 479

    CrossRef

  17. 17
    Sarah Payet, Martin Soubrier, Elodie Perrodeau, Thomas Bardin, Alain Cantagrel, Bernard Combe, Maxime Dougados, René-Marc Flipo, Xavier Le Loët, Thierry Shaeverbeke, Philippe Ravaud, Jacques-Eric Gottenberg, Xavier Mariette, Efficacy and Safety of Rituximab in Elderly Patients With Rheumatoid Arthritis Enrolled in a French Society of Rheumatology Registry, Arthritis Care & Research, 2014, 66, 9
  18. 18
    Felipe A. Castro, Xiangdong Liu, Asta Försti, Jianguang Ji, Jan Sundquist, Kristina Sundquist, Jill Koshiol, Kari Hemminki, Increased Risk of Hepatobiliary Cancers After Hospitalization for Autoimmune Disease, Clinical Gastroenterology and Hepatology, 2014, 12, 6, 1038

    CrossRef

  19. 19
    C. Kneitz, A. Strangfeld, K. Krüger, Prophylaxe und Behandlung von Infektionen beim älteren Rheumapatienten, Zeitschrift für Rheumatologie, 2014, 73, 3, 225

    CrossRef

  20. 20
    Ottokar Stundner, Thomas Danninger, Ya-Lin Chiu, Xuming Sun, Susan M. Goodman, Linda A. Russell, Mark Figgie, Madhu Mazumdar, Stavros G. Memtsoudis, Rheumatoid Arthritis vs Osteoarthritis in Patients Receiving Total Knee Arthroplasty: Perioperative Outcomes, The Journal of Arthroplasty, 2014, 29, 2, 308

    CrossRef

  21. 21
    Sarah K. Brode, Frances B. Jamieson, Ryan Ng, Michael A. Campitelli, Jeffrey C. Kwong, J. Michael Paterson, Ping Li, Alexandre Marchand-Austin, Claire Bombardier, Theodore K. Marras, Risk of Mycobacterial Infections Associated With Rheumatoid Arthritis in Ontario, Canada, Chest, 2014, 146, 3, 563

    CrossRef

  22. 22
    Christina Y. Ha, Risks of Infection among the Older Inflammatory Bowel Disease Patients, Current Treatment Options in Gastroenterology, 2014, 12, 3, 283

    CrossRef

  23. 23
    Tânia Santiago, José António P. Silva, Safety of low- to medium-dose glucocorticoid treatment in rheumatoid arthritis: myths and reality over the years, Annals of the New York Academy of Sciences, 2014, 1318, 1
  24. 24
    Marco Krasselt, Christoph Baerwald, The current relevance and use of prednisone in rheumatoid arthritis, Expert Review of Clinical Immunology, 2014, 10, 5, 557

    CrossRef

  25. 25
    Cecilia Mercieca, John R Kirwan, The intelligent use of systemic glucocorticoids in rheumatoid arthritis, Expert Review of Clinical Immunology, 2014, 10, 1, 143

    CrossRef

  26. 26
    Marlies C van der Goes, Johannes W Jacobs, Johannes W Bijlsma, The value of glucocorticoid co-therapy in different rheumatic diseases - positive and adverse effects, Arthritis Research & Therapy, 2014, 16, Suppl 2, S2

    CrossRef

  27. 27
    Cecilia P. Chung, Patricia Rohan, Shanthi Krishnaswami, Melissa L. McPheeters, A systematic review of validated methods for identifying patients with rheumatoid arthritis using administrative or claims data, Vaccine, 2013, 31, K41

    CrossRef

  28. 28
    T. Lequerré, G. Avenel, O. Vittecoq, Actualités thérapeutiques dans la polyarthrite rhumatoïde, La Revue de Médecine Interne, 2013, 34, 12, 754

    CrossRef

  29. 29
    Christina Y. Ha, Seymour Katz, Clinical implications of ageing for the management of IBD, Nature Reviews Gastroenterology & Hepatology, 2013, 11, 2, 128

    CrossRef

  30. 30
    Christina Y. Ha, Seymour Katz, Clinical Outcomes and Management of Inflammatory Bowel Disease in the Older Patient, Current Gastroenterology Reports, 2013, 15, 2

    CrossRef

  31. 31
    Mª Victoria Hernández, Raimon Sanmartí, Juan D. Cañete, Miguel A. Descalzo, Mercè Alsina, Loreto Carmona, Juan J. Gomez-Reino, Cutaneous Adverse Events During Treatment of Chronic Inflammatory Rheumatic Conditions With Tumor Necrosis Factor Antagonists: Study Using the Spanish Registry of Adverse Events of Biological Therapies in Rheumatic Diseases, Arthritis Care & Research, 2013, 65, 12
  32. 32
    N. Duru, M. C. van der Goes, J. W. G. Jacobs, T. Andrews, M. Boers, F. Buttgereit, N. Caeyers, M. Cutolo, S. Halliday, J. A. P. Da Silva, J. R. Kirwan, D. Ray, J. Rovensky, G. Severijns, R. Westhovens, J. W. J. Bijlsma, EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases, Annals of the Rheumatic Diseases, 2013, 72, 12, 1905

    CrossRef

  33. 33
    Christina Ha, Seymour Katz, Management of Inflammatory Bowel Disease in the Elderly: Do Biologicals Offer A Better Alternative?, Drugs & Aging, 2013, 30, 11, 871

    CrossRef

  34. 34
    Martin Soubrier, Zuzana Tatar, Marion Couderc, Sylvain Mathieu, Jean-Jacques Dubost, Rheumatoid Arthritis in the Elderly in the Era of Tight Control, Drugs & Aging, 2013, 30, 11, 863

    CrossRef

  35. 35
    J.L. Casals-Sánchez, C. Casals Vázquez, M.Á. Vázquez Sánchez, S. Giménez Basallote, Vacunas y actividades preventivas en pacientes con artritis inflamatorias, SEMERGEN - Medicina de Familia, 2013, 39, 7, 382

    CrossRef